BioNTech is a Germany-based biotechnology company that specializes in developing innovative immunotherapies for cancer and vaccines for infectious diseases, including COVID-19. The company’s oncology pipeline features a variety of drug classes, such as mRNA-based treatments designed to encode antigens and neoantigens, as well as cytokines, antibodies, cell therapies, bispecific antibodies, and antibody-drug conjugates. BioNTech's first commercialized product is the COVID-19 vaccine Comirnaty. The company has established partnerships with several major pharmaceutical firms, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab, to advance its therapeutic and vaccine development efforts.
InstaDeep is a creator of a platform for making decisions that will guarantee talent retention and offer training. The company's platform provides a variety of AI programs, such as enhanced pattern recognition, insights accelerated by GPUs, self-learning decision-making systems, machine learning, and predictive analytics to optimize decisions. This enables businesses to increase return on investments by enhancing manufacturing, logistics, mobility, and energy efficiency. InstaDeep was established on October 8, 2015 by Zohra Slim and Karim Beguir in London, England.
Kite - TCR therapy
Acquisition in 2021
TCR therapy is a type of cellular immunotherapy designed to redirect the patient’s immune system in order to recognize and target tumors.
Neon Therapeutics is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. The company's pipeline products are NEO-PV-01, NEO-PTC-01, and NEO-SV-01.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.